Option Volumes Soars Amid Opko Health Inc. (OPK) Breakout

Opko Health Inc. is up 9%, thanks to a licensing deal with Pfizer Inc.

Digital Content Group
Dec 15, 2014 at 1:48 PM
facebook twitter linkedin


Opko Health Inc. (NYSE:OPK) has surged roughly 9% to trade at $8.92, after striking a nearly $300 million drug-licensing deal with Pfizer Inc. (NYSE:PFE). Option traders have taken notice, too, as intraday volume is running at nearly triple the expected rate -- with possible buy-to-open activity at the January 2015 9-strike call.

Today's bullish gap has OPK trading above its year-to-date breakeven mark of $8.44, as well as several key trendlines. Specifically, the shares have broken north of their 80-, 160-, and 200-day moving averages, which have acted as levels of resistance in recent months. In fact, the last time the stock closed atop this trio of trendlines was Aug. 19.

Short-covering activity may be helping to fuel Opko Health Inc.'s (NYSE:OPK) intraday gains. More than one-fifth of the equity's float is dedicated to short interest, and it would take around six weeks to buy back these bearish bets, at OPK's average daily trading volume.

 

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 

 


 


 
Special Offers from Schaeffer's Trading Partners